Patient demographic information was compared between the PCOS and non-PCOS groups as a whole, and between patients who had AMH and 25(OH)D results and those who did not, to check for systematic selection bias due to missing data in the primary outcomes (Table 1). This evidence concerns the gene AMH and polycystic ovary syndrome.